Sugi Predict

Sugi Predict / Compounds / SCHEMBL2584799

SCHEMBL2584799

SCHEMBL2584799

CCn1c2ccccc2c2ccc(Br)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.56
▸ TP53 P04637 1/20 0.56
▸ KDM4E B2RXH2 7/20 0.56
▸ MEN1 O00255 4/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ HTT P42858 3/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ HPGD P15428 1/20 0.56
▸ HBB P68871 1/20 0.56
▸ TSPO P30536 1/20 0.50
▸ KDM1A O60341 1/20 0.50
▸ LMNA P02545 4/20 0.49
▸ PTGER4 P35408 1/20 0.48
▸ POLB P06746 2/20 0.48
▸ PKM P14618 1/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.47
▸ NSD2 O96028 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29556340 0.91 MAPT (0.44) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL19056399 0.91 MAPT (0.44) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL29773622 0.89 MAPT (0.65) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL871044 0.89 MAPT (0.65) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL26541551 0.87 MAPT (0.54) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL27551248 0.83 PGR (0.56) ALDH1A1TDP1
SCHEMBL15791594 0.83 MAPT (0.51) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL13979310 0.83 KDM4E (0.70) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL151563 0.82 ALDH1A1 (0.75) MAPTTP53KDM4EMEN1KMT2A
SCHEMBL29963695 0.82 ALDH1A1 (0.75) MAPTTP53KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014261-A1 TARGETED PROTEIN MODIFICATION WEATHERWAX BIOTECHNOLOGIES CORP (US) 2026-01-15 — — US disclosed
CN-116041392-B Compound containing phosphate group, preparation method and application thereof 中国科学院长春应用化学研究所 2024-11-12 — — CN disclosed
WO-2024112611-A1 TARGETED PROTEIN MODIFICATION WEATHERWAX BIOTECHNOLOGIES CORPORATION (US) 2024-05-30 — — WO disclosed
WO-2024076692-A1 HETEROBIFUNCTIONAL COMPOUNDS AS P53 ACETYLATORS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2024-04-11 — — WO disclosed
CN-116462709-A Phosphate group-containing compound, preparation method thereof and application thereof in perovskite light-emitting device 中国科学院长春应用化学研究所 2023-07-21 — — CN disclosed
CN-116041392-A Compound containing phosphate group, preparation method and application thereof 中国科学院长春应用化学研究所 2023-05-02 — — CN disclosed
CN-114805205-A Acridine compound and preparation method and application thereof 郑州大学 2022-07-29 — — CN disclosed
US-11177403-B2 Perovskite solar cell KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-16 — — US disclosed
US-10998501-B2 Material for organic electroluminescent device, organic electroluminescent device including the same and preparation method of triarylamine derivatives SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-04 — — US disclosed
WO-2021004391-A1 C-MYC PROTEIN INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州开拓药业股份有限公司 2021-01-14 — — WO disclosed
US-9017829-B2 Phenanthrocarbazole compound, and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2015-04-28 — — US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 — — US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 — — US disclosed
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2013-02-28 — — US disclosed
WO-2011139125-A2 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 (KR) 2011-11-10 — — WO disclosed
CN-1177350-A Imidazole derivatives and pharmaceutical compositions thereof YAMANOUCHI PHARMA CO LTD (JP) 1998-03-25 — — CN disclosed
EP-0820989-A1 IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1998-01-28 — — EP disclosed
US-5041238-A Long photochemical lifetimes; high power output; greater solubility EXCITON CHEMICAL COMPANY (US) 1991-08-20 — — US disclosed
US-5037578-A Light source excites dyes solution to generate coherent laser radiation EXCITON CHEMICAL COMPANY (US) 1991-08-06 — — US disclosed
US-4006017-A Photoconductive composition, article and process XEROX CORPORATION (US) 1977-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10998501-B2 Material for organic electroluminescent device, organic electroluminescent device including the same and preparation method of triarylamine derivatives TDO2, LEO1, COMT MAPT 2389/4885TP53 4452/4885KDM4E 624/4885
US-20260014261-A1 TARGETED PROTEIN MODIFICATION MDM2, TP53, VHL MAPT 963/4885TP53 2/4885KDM4E 1602/4885
US-20130048975-A1 PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME PPOX, ORC3, CACNA2D3 MAPT 589/4885TP53 1400/4885KDM4E 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.